Growing community of inventors

Chicago, IL, United States of America

Subbarao Nallagatla

Average Co-Inventor Count = 5.07

ph-index = 4

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 25

Subbarao NallagatlaSergei M Gryaznov (5 patents)Subbarao NallagatlaAleksandar Filip Radovic-Moreno (5 patents)Subbarao NallagatlaChristopher C Mader (5 patents)Subbarao NallagatlaRichard Kang (4 patents)Subbarao NallagatlaWarefta Hasan (2 patents)Subbarao NallagatlaAaron Love (2 patents)Subbarao NallagatlaEkambar Kandimalla (1 patent)Subbarao NallagatlaBart Anderson (1 patent)Subbarao NallagatlaSubbarao Nallagatla (6 patents)Sergei M GryaznovSergei M Gryaznov (83 patents)Aleksandar Filip Radovic-MorenoAleksandar Filip Radovic-Moreno (22 patents)Christopher C MaderChristopher C Mader (10 patents)Richard KangRichard Kang (7 patents)Warefta HasanWarefta Hasan (2 patents)Aaron LoveAaron Love (2 patents)Ekambar KandimallaEkambar Kandimalla (2 patents)Bart AndersonBart Anderson (1 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Exicure, Inc. (3 from 9 patents)

2. Exicure Operating Company (3 from 4 patents)


6 patents:

1. 11957788 - Multivalent delivery of immune modulators by liposomal spherical nucleic acids for prophylactic or therapeutic applications

2. 11696954 - Synthesis of spherical nucleic acids using lipophilic moieties

3. 11123294 - Multivalent delivery of immune modulators by liposomal spherical nucleic acids for prophylactic or therapeutic applications

4. 10894963 - Spherical nucleic acid-based constructs as immunostimulatory agents for prophylactic and therapeutic use

5. 10837018 - Spherical nucleic acid-based constructs as immunostimulatory agents for prophylactic and therapeutic use

6. 10434064 - Multivalent delivery of immune modulators by liposomal spherical nucleic acids for prophylactic or therapeutic applications

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/10/2025
Loading…